December 21, 2015
Toshiba Medical Systems Corporation (“TMSC”, President: Toshio Takiguchi; Headqurters: Otawara, Tochigi, Japan), has decided to work on inviting outside majority shareholder(s), in order to strengthen the financial ability to further realize our growth strategies, following the announcement of “Toshiba Revitalization Action Plan” by Toshiba Corporation.
December 1, 2015
Toshiba Corporation and Toshiba Medical Systems Corporation have developed a technology for displaying expansive virtual reality images inside the bore*1 of MRI systems.
November 16, 2015
Toshiba Medical Systems Corporation (headquarters: Otawara, Tochigi; president: Toshio Takiguchi) has signed an OEM agreement with British company OptiGene Limited (“OptiGene”; headquarters: Unit 5, Blatchford Road, Horsham, West Sussex RH13 5QR, United Kingdom; president: Michael Andreou) for its gene fluorescent detector that employs isothermal amplification (“Detector”) .
October 14, 2015
Toshiba Medical SystemToshiba Medical Systems Corporation (President: Toshio Takiguchi; Headquarters: Otawara, Tochigi, Japan) has launched global sales of the Toshiba 3-tesla MRI system Vantage Titan™ 3T / iS Edition (iS: intelligent Solution).s Corporation (President: Toshio Takiguchi; Headquarters: Otawara, Tochigi, Japan) has launched global sales of the Toshiba 3-tesla MRI system Vantage Titan™ 3T / iS Edition (iS: intelligent Solution).
October 2, 2015
Toshiba Medical Systems Europe B.V. (headquarters: Zoetermeer, Netherlands; President: Hiroyuki Tachikawa, “TMSE”), which is a regional subsidiary of Toshiba Medical Systems Corporation (headquarters: Otawara, Tochigi Prefecture, Japan; President: Toshio Takiguchi, “TMSC”) signed a 5-year contract with FC Barcelona to be its official medical systems partner.
September 7, 2015
Medical Excellence JAPAN (MEJ; President: Shuzo Yamamoto MD) and Toshiba Medical Systems Corporation (TMSC; President: Toshio Takiguchi) have established the Russia-Japan Cardiac Imaging Training Center in cooperation with I.M. Sechenov First Moscow State Medical University (location: Moscow; Rector: Prof. Petr V. Glybochko) and A.L. Myasnikov Institute of Clinical Cardiology (location: Moscow; Director: Prof. Yevgeny I. Chazov). An opening ceremony will be held at the site at 11:00 a.m. on September 7.
July 1, 2015
Otawara, Japan, July 1st, 2015 — achieving a significant milestone in the advancement of computed tomography (CT) in the practice of diagnostic imaging, Toshiba Medical Systems Co., Ltd. (Headquarters: Tochigi Prefecture Otawara President: Takiguchi Toshio) announced the production of the 1000th Aquilion ONE™, launched in 2007 as the world’s first 320-row area detector CT, able to scan 16cm at once.
April 9, 2015
Collaboration signed to enhance access to proton therapy and carbon therapy worldwide Toshiba Medical Systems Corporation to become IBA's Proteus®ONE distributor in Japan IBA to become Toshiba's carbon therapy agent outside of Japan
March 30, 2015
Otawara, Japan, March 30, 2015 - Toshiba Medical Systems Corporation (President: Toshio Takiguchi; Headquarters: Otawara, Tochigi, Japan) has launched global sales of the Toshiba 1.5-tesla MRI system Vantage Titan™ with the latest version of the M-Power™ platform V3.1.
February 11, 2015
Penang, Malaysia - Toshiba Medical Systems Manufacturing Asia Sdn. Bhd. (TMMA), a wholly-owned Malaysian subsidiary of Toshiba Medical Systems Corporation was officially launched today.
January 6, 2015
Otawara, Japan, January 6, 2015 - In 2006, the Food and Drug Administration (FDA) released a public health advisory warning of the risk of developing nephrogenic systemic fibrosis (NSF) associated with the use of all gadolinium-containing contrast agents in patients with end stage renal disease or acute renal failure, as well as patients with chronic kidney disease.
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION
The site you see is the Canon Medical Global website. If you choose region / language, we will link to each regional site.